FDA Inspection 1113410 — Brett S. Lumpkins, PhD
The FDA completed an inspection of Brett S. Lumpkins, PhD on November 20, 2019 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 20, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Bioresearch Monitoring
- Location
- Athens, GA (United States)
Additional Details
Clinical Investigator (CI)